tiprankstipranks
Trending News
More News >
Halozyme Therapeutics (HALO)
NASDAQ:HALO

Compare Halozyme (HALO) vs. Competitors

Compare
1,135 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Halozyme
$72.96
$8.58B
15.34
35.54%
4 Buy
2 Hold
1 Sell
Moderate Buy
Corcept Therapeutics
$36.35
$3.90B
42.32
-28.30%
4 Buy
1 Hold
1 Sell
Moderate Buy
Ionis Pharmaceuticals
$79.48
$12.77B
-46.09
141.27%
13 Buy
1 Hold
0 Sell
Strong Buy
Bio-Techne
$68.40
$10.66B
139.82
-8.47%
6 Buy
3 Hold
0 Sell
Moderate Buy
Moderna
$39.60
$15.86B
-5.03
17.76%
1 Buy
15 Hold
4 Sell
Hold
Roivant Sciences
$23.44
$16.56B
-43.09
117.64%
7 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HALO
Halozyme
72.96
18.45
33.85%
CORT
Corcept Therapeutics
37.04
-16.74
-31.13%
IONS
Ionis Pharmaceuticals
78.87
45.66
137.49%
TECH
Bio-Techne
68.40
-6.41
-8.57%
MRNA
Moderna
40.58
5.81
16.71%
ROIV
Roivant Sciences
23.81
12.74
115.09%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts